From Kineta Gets $15M in New Cancer Drug Partnership with Pfizer:

Kristin Bedard
Kristin Bedard—

Bedard is chief scientific officer, immuno-oncology and senior vice president, discovery at Kineta, a Seattle-based biotech. Image courtesy of Kineta.

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

© 2007-2020, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.